← Open Payments lookup

SUSETTE DEAN: Open Payments

NPI 1821742537 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,256 in 55 payments from 18 companies in 2025. Trend: 2023 $330 · 2024 $187 · 2025 $3,256

Food & beverage: $2,414Consulting: $820Travel & lodging: $22
CompanyPaymentsAmount
Gilead Sciences, Inc.8$1,147
Madrigal Pharmaceuticals19$542
Regeneron Healthcare Solutions, Inc.4$243
Novo Nordisk Inc2$208
Janssen Biotech, Inc.3$173
Ardelyx, Inc.4$153
Janssen Scientific Affairs, LLC1$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$118
Intercept Pharmaceuticals, Inc.1$116
ABBVIE INC.1$115

Products named: Livdelzi, REZDIFFRA, DUPIXENT, TREMFYA, IBSRELA, Ozempic, XIFAXAN, OCALIVA.

Industry payments across NY — which companies pay providers there.